CC
Get informed when a big investor buys or sells
+ FollowOvervalued by 255.2% based on the discounted cash flow analysis.
| Market cap | $2.37 Billion |
|---|---|
| Enterprise Value | $5.76 Billion |
| Dividend Yield | $0.35 (2.22%) |
| Earnings per Share | $-2.57 |
| Beta | 1.4 |
| Outstanding Shares | 151,381,215 |
| P/E Ratio | -7.88 |
|---|---|
| PEG | 28.04 |
| Price to Sales | 0.4 |
| Price to Book Ratio | -15.26 |
| Enterprise Value to Revenue | 0.99 |
| Enterprise Value to EBIT | -8.26 |
| Enterprise Value to Net Income | -19 |
| Total Debt to Enterprise | 0.71 |
| Debt to Equity | -82.92 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4107▲ 10.03% |
|---|---|
| Total Calls | 28,000▼ 99.50% |
| Total Puts | 11,500▼ 99.34% |
Holdings and activity of institutional investors.
| Ownership % | 26.53%▼ 60.92% |
|---|---|
| Total Invested | $816.66M▼ 71.75% |
| Investors Holding | 234▼ 245.00% |
No data
The Chemours Company is a global leader in Titanium Technologies, Fluoroproducts, and Chemical Solutions, providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemi...